HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26

Advances in Experimental Medicine and Biology

Volumn 421, Issue , 1997, Pages 185-192

  Valenzuela, Agustín ^a   Blanco, Julià ^b   Callebaut, Christian ^b   Jacotot, Etienne ^b   Lluis, Carmen ^a   Hovanessian, Ara G ^b   Franco, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; BINDING PROTEIN; CD4 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLYCOPROTEIN GP 120;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME BINDING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE;

ADA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030860316     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9613-1_24     Document Type: Article

References (32)

1. N.M. Kredich, M. S. Hershfield, in The Metabolic Basis of Inherited Disease S. C. R., B. A. L., S W.S., V. D., Eds. 1989) pp. 1045-1075.
2. J. M. Aran, D. Colomer, E. Matutes, J. L. Vives-Corrons, R. Franco, J Histochem. Cytochem. 39, 1001-1008 (1991).
3. J. Kameoka, T. Tanaka, Y. Nojima, S. F. Schlossman, C. Morimoto, Science 261., 466-469 (1993).
4. B. Fleischer, Immunol. Today 15, 180-184 (1994).
5. Y. Torimoto, et al., J Immunol 147, 2514-7 (1991).
6. H. W. Mittrücker, C. Steeg, B. Malissen, B. Fleischer, Eur. J. Immunol. 25, 295-297 (1995).
7. R.-P. Dong, et al., J. Immunology. 156., 1349-1355. (1996).
8. M. Martin, J. Huguet, J. J. Centelles, R. Franco, J. Immunol. 155., 0001-0014 (1995).
9. T. Oravecz, et al., Nature Medicine. 1., 919-926 (1995).
10. C. Callebaut, E. Jacotot, B. Krust, A. G. Hovanessian, Science 262, 2045-2052 (1993).
11. C. Callebaut, E. Jacotot, B. Krust, A. Hovanessian and C. Broder, et al., Science 264, 1156-1165 (1994).
12. C. Morimoto, et al., Proc. Natl. Acad. Sci. USA 91, 9960-9964 (1994).
13. A. De Pasquale, L. Ginaldi, P. Limoncelli, D. Quaglino, Acta Haemat. 81, 19-21 (1989).
14. M. Valle Blazquez, et al., J.Immunology. 149, 3073-3077 (1992).
15. G. Vanham, et al., J. AIDS 6, 749-757 (1993).
16. M.-L. Gougeon. et al., Res. Immunol. 147, 5-8 (1996).
17. E. Jacotot, et al., Virology 223, 318-330 (1996).
18. C. Callebaut, A. G. Hovanessian, Res.Virol. 147, 67-69 (1996).
19. L. T. Chin, et al., Immunology Letters 44, 25-30 (1995).
20. P. S. Linsley, J. A. Ledbetter, E. Kinney-Thomas, S. L. Hu, J. Virol. 62, 3695-3702 (1988).
21. J. Blanco, et al., Exp. Cell Res. 225, 102-111 (1996).
22. A. G. Laurent-Crawford and A. G. Hovanessian, J. Gen. Virol. 74, 2619-2628 (1993).
23. Q. J. Sattentau, R. A. Weiss, Cell 52, 631-633 (1988).
24. Y. H. Wang, A. H. Davies, I. M. Jones, Virology 208, 142-146 (1995).
25. I. De Meester, et al., Eur J Immunol 24, 566-70 (1994).
26. J. P. Moore, Q. J. Sattentau, R. Wyatt, J. Sodroski, J Virol 68, 469-84 (1994).
27. G. Roderiquez, et al., J. Virol. 69., 2233-2239 (1995).
28. T. Dragic, et al., Nature 381, 667-673 (1996).
29. Y. Feng, C. C. Broder, P. E. Kennedy, E. A. Berger, Science 272, 872-876 (1996).
30. T. Oravecz, M. Pall, M. A. Norcross, J. Immunol. 157, 1329-1332 (1996).
31. H. C. Lane, et al., N Engl J Med 313, 79-84 (1985).
32. J. L. Murray, et al., Blond 65, 1318-24 (1985).